During the past decade, Zala Megyei Kórház; SZEMESZET conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zala Megyei Kórház; SZEMESZET" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Zala Megyei Kórház; SZEMESZET" are "Diabetic Macular Edema" (2 trials), "Central Retinal Vein Occlusion" (1 trials), "Hemiretinal Vein Occlusion" (1 trials), "Macular Edema" (1 trials) and "Neovascular Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Zala Megyei Kórház; SZEMESZET" in a lesser frequency.

Most popular intervention types in "Zala Megyei Kórház; SZEMESZET" are "Drug" (5 trials), "Procedure" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (5 trials), "Sham Procedure" (5 trials) and "Aflibercept" (3 trials). Other intervention names were less common.

The vast majority of trials in "Zala Megyei Kórház; SZEMESZET" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Zala Megyei Kórház; SZEMESZET". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Zala Megyei Kórház; SZEMESZET, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zala Megyei Kórház; SZEMESZET, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".